It is prescribed in the next cases:
- Ovulation induction in women undergoing assisted reproductive techniques after follicle development using FSH and other medications (LH, GnRH analogues, or GnRH antagonists).
- Absence of LH halfway through the menstrual cycle while undergoing treatments containing clomiphene
- Inappropriate increase of LH levels halfway through the menstrual cycle while undergoing treatments containing clomiphene
Our editors have made great efforts to create this content for you. By sharing this post, you are helping us to keep ourselves motivated to work even harder.
Authors and contributors
Bachelor's Degree in Biology from the University of Valencia (UV). Postgraduate Course in Biotechnology of Human Assisted Reproduction from the Miguel Hernández University of Elche (UMH). Experience managing Embryology and Andrology Labs at Centro Médico Manzanera (Logroño, Spain). More information about Neus Ferrando Gilabert
Adapted into english by:
Bachelor of Arts in Translation and Interpreting (English, Spanish, Catalan, German) from the University of Valencia (UV) and Heriot-Watt University, Riccarton Campus (Edinburgh, UK). Postgraduate Course in Legal Translation from the University of Valencia. Specialist in Medical Translation, with several years of experience in the field of Assisted Reproduction. More information about Sandra Fernández